The Use of Vascular Endothelial Growth Factor Inhibitors in Patients with Proliferative Diabetic Retinopathy
Diabetic retinopathy (DR) have been taking a leading position among retinal disorders, causing a persistent and significant decrease in visual functions. The base of the disease is a retinal vascular microangiopathy, which induces a tissue ischemia and excessive production of vascular endothelial gr...
Saved in:
Main Authors: | V. Yu. Evgrafov, G. R. Kudasheva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ophthalmology Publishing Group
2022-07-01
|
Series: | Oftalʹmologiâ |
Subjects: | |
Online Access: | https://www.ophthalmojournal.com/opht/article/view/1867 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EFFECT OF SURGICAL TREATMENT OF PATIENTS WITH PROLIFERATIVE DIABETIC RETINOPATHY COMPLICATED BY HEMOPHTHALMIA
by: V. D. Zaharov, et al.
Published: (2017-10-01) -
Applying Lucentis for the treatment of retinopathy of prematurity
by: S. V. Lesovoy, et al.
Published: (2022-12-01) -
Meta-Analysis of risk factors and clinical significance for postoperative vitreous hemorrhage in proliferative diabetic retinopathy
by: Cheng Tang, et al.
Published: (2025-08-01) -
Role of Vitrectomy in the Treatment of Diabetic Retinopathy
by: D. V. Petrachkov, et al.
Published: (2021-10-01) -
PERBEDAAN QUALITY OF LIFE PADA PENDERITA PROLIFERATIVE DIABETIC RETINOPATHY DENGAN DAN TANPA LASER PANRETINAL PHOTOCOAGULATION
by: Yulian Fajariyanti, et al.
Published: (2017-06-01)